tiprankstipranks
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market
Holding ERNA?
Track your performance easily

Eterna Therapeutics (ERNA) Financial Statements

215 Followers

Eterna Therapeutics Financial Overview

Eterna Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.308; its P/E ratio is -0.07; Eterna Therapeutics is scheduled to report earnings on April 14, 2023, and the estimated EPS forecast is $-2.40. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 487.00K$ 47.00K$ 47.00K$ -4.00K$ 51.00K
Gross Profit$ 547.00K$ -48.00K$ -14.00K$ -141.00K$ -69.00K
EBIT$ -2.26M$ -5.50M$ -6.17M$ -5.62M$ -5.49M
EBITDA$ -579.00K$ -4.45M$ -5.18M$ -4.88M$ -4.97M
Net Income Common Stockholders$ -26.60M$ -5.54M$ -6.60M$ -6.18M$ -5.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.30M$ 2.60M$ 5.12M$ 7.58M$ 4.55M
Total Assets$ 7.72M$ 46.49M$ 49.66M$ 49.13M$ 52.25M
Total Debt$ 33.55M$ 49.20M$ 47.45M$ 41.84M$ 39.60M
Net Debt$ 29.25M$ 46.60M$ 42.34M$ 34.27M$ 35.05M
Total Liabilities$ 53.11M$ 55.01M$ 53.07M$ 46.90M$ 48.69M
Stockholders Equity$ -45.39M$ -8.53M$ -3.41M$ 2.23M$ 3.56M
Cash Flow-
Free Cash Flow$ -6.32M$ -2.55M$ -3.80M$ -4.72M$ -5.83M
Operating Cash Flow$ -6.30M$ -2.30M$ -3.70M$ -4.70M$ -5.83M
Investing Cash Flow$ -19.00K$ -249.00K$ -97.00K$ -19.00K-
Financing Cash Flow$ 3.89M$ -22.00K$ 1.39M$ 7.70M$ 8.54M
Currency in USD

Eterna Therapeutics Earnings and Revenue History

Eterna Therapeutics Debt to Assets

Eterna Therapeutics Cash Flow

Eterna Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis